BridgeBio Announces Agreement With U.S. Govt To Improve Affordability & Access To Critical Medicines

Sept. 1 (Reuters) - BridgeBio Pharma, Inc. BBIO.O:

• BridgeBio announces agreement with U.S. government to improve affordability and access to critical medicines for Americans
• BridgeBio Pharma - to expand state Medicaid access to marketed medicine via generous model
• BridgeBio Pharma - to offer Attruby via Medicare Part D without future pricing mandates
• BridgeBio Pharma - agreement does not impact ForgingBridges copay assistance program
• BridgeBio Pharma - does not expect future pricing mandates; terms remain confidential

Source text: ID:nGNX7p6LNz

Further company coverage: BBIO.O